Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
It has widely been known that mutual crosstalk between myeloma cells and mesenchymal stromal cells (MSCs) in bone marrow is important for progression of multiple myeloma. In this study, we clearly demonstrated that lysophosphatidic acid (LPA), a kind of lipid mediators, drastically changes phenotypes of MSCs, namely, myeloma-supportive or myeloma-suppressive. From the results by gene silencing of MSCs using siRNA, signaling via LPA receptor subtype 1 (LPA1) and 3 (LPA3) modulates cellular senescence of MSCs positively and negatively, respectively, and also regulated proliferation of myeloma cells positively and negatively, respectively. This study produced clear evidence toward etiology of multiple myeloma that its incidence rate and severity proportionally increase with aging.
|